LIVE24 Aug 2026, 08:01 PM IST
Home / IPO / Vijaypd Ceutical
LISTEDSME

Vijaypd Ceutical IPO

Open 29th Sep 2025 · Close 1st Oct 2025 · Listing 7th Oct 2025

Price BandTBA
Live GMP₹0.00
Subscription1.37×
Issue Size₹19.25 Cr
Allotment3rd Oct 2025

At a glance

Updated 2026-08-24

Vijaypd Ceutical is a SME IPO with an issue size of ₹19.25 crore, proposed for listing on NSE SME. The offer opens on 29th Sep 2025 and closes on 1st Oct 2025. The issue structure includes a fresh issue of ₹18.26 crore.

Issue details

Listing atNSE SME
Issue typeFixed Price Issue
Issue size₹19.25 Cr
Fresh issue₹18.26 Cr
Face value₹10
Price band—–—
Allotment3rd Oct 2025
Listing7th Oct 2025

Grey market

GMP page ↗
Latest GMP₹0.00
GMP / upper priceNO DATA
Est. listing₹35.00
GMP is unofficial sentiment data, not an exchange price.

Timeline

Opens29th Sep 2025
Closes1st Oct 2025
Allotment3rd Oct 2025
Refund6th Oct 2025
Demat6th Oct 2025
Listing7th Oct 2025

Subscription demand

Full bidding ↗
Total1.37×

Lot size

InvestorLotsSharesAmount
Minimum Bid18000

Company

Use of proceeds

ObjectAmount
Funding of capital expenditure requirements of the company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC-Shrirampur, Ahmednagar, Maharashtra₹10.83 Cr
Repayment/prepayment of all or certain of the borrowings availed of by the Company₹5.10 Cr
General Corporate Purposes₹0.74 Cr
Issue Expenses₹2.58 Cr
Total₹19.25 Cr

31 Mar 2023

Assets32.87
Total Income50.59
EBITDA1.32
Profit After Tax0.18
NET Worth4.93
Total Borrowing25.56

31 Mar 2024

Assets33.27
Total Income54.34
EBITDA4.87
Profit After Tax1.65
NET Worth1.00
Total Borrowing30.04

31 Mar 2025

Assets57.15
Total Income107.59
EBITDA8.59
Profit After Tax4.80
NET Worth32.17
Reserves and Surplus18.14
Total Borrowing21.77
Trend chart₹ crore

KPIs

KPIMar 31, 2025
ROE28.91%
ROCE17.30%
Debt / Equity0.68%
RoNW14.91%
PAT Margin4.49%
EBITDA Margin8.04%

Issue expenses

ExpenseAmount
Funding of capital expenditure requirements of the company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC-Shrirampur, Ahmednagar, Maharashtra₹10.83 Cr
Repayment/prepayment of all or certain of the borrowings availed of by the Company₹5.10 Cr
General Corporate Purposes₹0.74 Cr
Issue Expenses₹2.58 Cr
Total₹19.25 Cr

Registrar & lead managers

Registrar

Kfin Technologies Ltd.

Lead managers

  • Smart Horizon Capital Advisors...

Offer documents

Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.